Yunhu Song

Trastuzumab Provides a Comparable Prognosis in Patients With HER2-Positive Breast Cancer to Those With HER2-Negative Breast Cancer: Post Hoc Analyses of a Randomized Controlled Trial of Post-Mastectomy Hypofractionated Radiotherapy

Shulian Wang, J. Jin, Ye-Xiong Li, 2021, Frontiers in Oncology.

Timing of postmastectomy radiotherapy following adjuvant chemotherapy for high-risk breast cancer: A post hoc analysis of a randomised controlled clinical trial.

Shulian Wang, J. Jin, Ye-Xiong Li, 2022, European journal of cancer.

Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial.

Wei Yang, Shulian Wang, J. Jin, 2022, Practical radiation oncology.

Quality of Life After Partial or Whole-Breast Irradiation in Breast-Conserving Therapy for Low-Risk Breast Cancer: 1-Year Results of a Phase 2 Randomized Controlled Trial

Chen Hu, Shulian Wang, J. Jin, 2021, Frontiers in Oncology.

Radiation-Induced Lymphopenia Predicts Poorer Prognosis in Patients with Breast Cancer: A Post-Hoc Analysis of a Randomized Controlled Trial of Postmastectomy Hypofractionated Radiotherapy.

Shulian Wang, J. Jin, H. Fang, 2020, International journal of radiation oncology, biology, physics.

Comparison of supraclavicular surgery plus radiotherapy versus radiotherapy alone in breast cancer patients with synchronous ipsilateral supraclavicular lymph node metastasis: a multicenter retrospective study.

Shulian Wang, H. Fang, H. Jing, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Biological background of the genomic variations of cf-DNA in healthy individuals

M. Ye, Changli Wang, Y. Wang, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.

Breast-conserving surgery versus mastectomy for treatment of breast cancer after neoadjuvant chemotherapy

Shulian Wang, J. Jin, H. Fang, 2023, Frontiers in oncology.